Mathews Journal of Pharmaceutical Science (MJPS; ISSN: 2474-753X) is international scholarly journal that publishes original research pertaining to diverse pharmaceutical science related topics, such as pro-drug development, drug delivery, drug action, clinical research, drug stability, dosage form design, rational use of pharmacotherapy, metabolic disposition of bioactive agents, targeted drug delivery, regulatory affairs, pharmaceutical biotechnology, pharmacokinetics, pharmacodynamics, ADME, pharmaceutical analysis, bioequivalence and bioavailability, molecular pharmaceutics, biopharmaceutics, microencapsulation, and protein-peptide chemistry with specific focus on pharmaceutical technology.
Special impetus is placed on papers related to drug safety and dealing with topics, such as pharmacoepidemiology, pharmacovigilance, risk management, benefit-risk assessment, and medication error prevention.
This leading journal on the field of Pharmacy and Pharmacology publishes critical reviews, perspectives, commentaries, and original research articles at the interface of disciplines itemized within pharmaceutical and related sciences, and takes great pride in keeping pace with latest research on how drug action/activity may be optimized using new technologies.
Why publish with us?
High Visibility: MJPS follows open access policy, thereby allowing the published articles to be accesses around the globe.
Promotion in Social Media: MJPS believes that serving the authors includes aggressively promoting their articles on social media platforms, and thereby ensuring them higher visibility.
Rigorous peer review: Every manuscript submitted undergoes a thorough and rigorous double-blind peer-review. This process eliminates subjective judgments and bias from the decision making process.
We welcome all types of articles related to Pharmaceutical Science. For submission assistance contact: i[email protected]. Please follow the Author Guidelines.
If you are not sure whether your work is suitable for this journal, please email us at i[email protected] or call us at +1-606-405–6566.
Published : 25th November 2023
Authors : Qadeer Ahmed, Muhammad Talha, Umer Ishtiaq, Saba Khurshid, Kaif Akbar, Urwa Amir, Muhammad Rehan, Ovais Ullah Shirazi, Shahid Latif, Zunaira Akbar, Iram Batool, Ali Akhtar*, Samreen Fatima
Citation : Ahmed Q, et al. (2023). Quality of Life and Medication Adherence in Rheumatoid Arthritis Patients. Mathews J Pharma Sci. 7(4):24.
Published : 03rd November 2023
Authors : Dadier Antonio Arroyo1,2,*, Linda Atencio1, Jorge Pérez Velásquez3, María Camila Coronado1, Meribeth Henry4, Maria Alejandra Suarez2, Daniela Katerine Rivera2
Citation : Arroyo DA, et al. (2023). Desensitization in a Patient with Hypersensitivity to the Iodinated Contrast Medium Iopromide: A Clinical Case Report. Mathews J Pharma Sci. 7(3):23.
Published : 17th October 2023
Author : Raúl Isea*
Citation : Isea R. (2023). We Continue to Battle with Diseases that are Difficult to Diagnose and Cure in the 21st Century. Mathews J Pharma Sci. 7(3):22.
Published : 11th October 2023
Authors : Allen B Richon1,*, Merry Ambos Richon2
Citation : Richon AB, et al. (2023). Four-Week Safety and Acceptability Study of 15% Bromelain Topical Lotion: An Open Label, Non-Comparative, Triple-Arm Study. Mathews J Pharma Sci. 7(3):21.
Published : 05th June 2023
Authors : Nkechi J Onyeukwu1, Samuel J Bunu2,*,Tologbonse A Adedoyin1, Ngozi A Onwuka1
Citation : Onyeukwu NJ, et al. (2023). Comparative Analysis of Petrochemicals Effects on Ocular Cavity: Prevalence and Pharmaceutical Interventions in the Niger Delta, Nigeria. Mathews J Pharma Sci. 7(2):20.
Published : 04th April 2023
Authors : Naresh Kshirasagar1*, Srilatha Malvey2, Gudikandula Harika3, Mallam Ranadheer Kumar1
Citation : Kshirasagar N, et al. (2023). Formulation and Evaluation of Flurbiprofen Loaded Microsponges in Capsule for Sustained Drug Delivery. Mathews J Pharma Sci. 7(2):16.